Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, has entered into an exclusive licensing agreement (“Agreement”) with UK-based specialist pharmaceutical company Viramal Limited (“Viramal”) for an innovative Women’s Health portfolio. Under the agreement, Aspen will have exclusive rights to launch and commercialize selected products from Viramal’s portfolio in Europe, the Middle East, Brazil and Mexico.
Aspen contributed to the Health Works – Unlocking Local Pharma Manufacturing session, focused on scaling regional production, resilience, and jobs. Lorraine shared Aspen’s growth journey and key enablers to expand access to medicines—highlighting partnerships, technology transfer, and global mechanisms like WHO prequalification and PEPFAR.
Discussions reinforced the urgency of progress through regulatory harmonisation, pooled procurement, demand certainty, and strong IP partnerships.
